We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Justices Told FDA's 'Smoking Gun' Sinks Fosamax MDL

Law360 (September 14, 2018, 7:55 PM EDT) -- Merck Sharp & Dohme Corp. has told the U.S. Supreme Court that “smoking gun” evidence from the U.S. Food and Drug Administration should sink a Third Circuit decision reviving multidistrict litigation over the company’s alleged failure to warn about a risk of femoral fractures from its osteoporosis drug Fosamax.

A circuit panel had concluded that jurors could find the agency would have approved a differently worded warning from Merck. But the FDA has said it rejected the warning due to “‘the agency’s determination that the data...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Merck Sharp & Dohme Corp., Petitioner v. Doris Albrecht, et al.


Case Number

17-290

Court

Supreme Court

Nature of Suit

4365 Personal Injury-Product Liability

Date Filed

August 24, 2017

Law Firms

Companies

Government Agencies

Judge Analytics

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.